Health Information Center

Global healthcare market is evolving from traditional healthcare system to modern healthcare system of E-health which minimizes the physical movement of patients and enhances the coverage of healthcare services. As the world population is aging, it has resulted in increase of global healthcare expenditure. The major increase in healthcare expenditure is being witnessed in developed nations where population is ageing at a higher pace compared to less developed nations. Aging population has resulted in increase in demand of healthcare services which is already in an over-pressurized state.

It is now believed that telemedicine is going to be an important component of the modern healthcare system which will ease the pressure over the existing healthcare system which is suffering from problems like lack of required number of physicians, high cost and limited reach in the rural areas. Telemedicine, being a component of E-health, is a provision of healthcare services that uses telecommunication technology and multimedia equipment to provide healthcare solutions over a geographic distance. Continue reading ‘New Report "analysis Of Telemedicine Market" Available Through Aarkstore Enterprise’ »

Axcan Pharma Inc.-Company Report provides up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies.

Scope of the reports

Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and business description along with detail on the company’s management team and its products. . Continue reading ‘Axcan Pharma Inc.-Company Report’ »

Cancer Head and Neck Cancer Therapy Area Pipeline Report

This report contains detailed information on the head and neck cancer drug pipeline. This report provides insight into the pipeline status of head and neck cancer drugs by company and by stage as well as a summary of the latest news and developments in this area. ( http://www.bharatbook.com/detail.asp?id=126756&rt=Cancer-Head-and-Neck-Cancer-Therapy-Area-Pipeline-Report.html )

Scope of the report:

Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area. Continue reading ‘Cancer Head And Neck Cancer Therapy Area Pipeline Report’ »

Alliance Pharma plc-Company Report

Bharatbook.com added a new report on “Alliance Pharma plc-Company Report” into its market report catalogue for reselling.

Alliance Pharma plc-Company Report provides up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies.

Scope of the reports

Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and business description along with detail on the company’s management team and its products. . Continue reading ‘Alliance Pharma plc-Company Report’ »

Major developments are likely in both the IVD market and in imaging-based modalities, like computed tomography, with the emphasis being upon the personalized medicine approach, where demand will come from physicians, patients and payors – all of whom want more effective treatments and value for money.

This report analyzes the latest innovations in oncology diagnostics and identifies the most exciting new technologies and trends, ranging from body imaging and cytology to molecular diagnostics and pharmacogenomics. The report also identifies the key challenges facing innovative diagnostics companies.

Key Features of this report

•Analysis the latest innovations in diagnostics imaging in the oncology sector, covering Magnetic Resonance Imaging (MRI), x-ray, Computed Tomography (CT), ultrasound, Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT) and Flow Cytometry.
•Analyzes the latest innovations in molecular diagnostics and how they impact the diagnostics market. The report covers technology including fluorescence in situ hybridization (FISH), polymerase chain reaction (PCR), HPV testing, immunoassays & biomarkers, microarrays and comparative genomic hybridization (CGH). Continue reading ‘Innovations In Oncology Diagnostics: Technological Advances, Growth Opportunities And Future Market Outlook’ »

Preclinical Models: Innovative solutions to accelerate drug discovery and development

Preclinical models are developed to test lead compounds for toxicity and efficacy. They are valuable tools to minimize development costs and reduce failures prior to commencement of human trials. Problems with traditional animal models such as cost, ethics, and suitability has prompted researchers to develop new models and systems to overcome such disadvantages. Continue reading ‘Preclinical Models – Innovative Solutions To Accelerate Drug Discovery And Development’ »

Oncothyreon, Inc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of development, and competitors by therapeutic indication. The report also includes recent company news updates.

Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood of clinical success for each pipeline product. Every Competitor Report compares the company against its primary competitors by individual therapeutic indication. Continue reading ‘Oncothyreon, Inc.-Therapeutic Competitors’ »

Opticians & Optical Goods – Market Assessment

This Market Assessment report provides an analysis of the opticians and optical goods market, which includes spectacles, contact lenses and solutions, laser eye treatment, sight tests and general ophthalmic services. It updates a previous Opticians & Optical Goods Market Assessment report published in August 2008. ( http://www.bharatbook.com/detail.asp?id=83563&rt=Opticians-Optical-Goods-Market-Assessment.html )

The market suffered the impacts of the recession in 2009 and several sectors experienced falling revenues. The downturn was the first reversal in an upward sales trend that had lasted for some years. Expenditure by opticians and suppliers of optical goods in areas such as main media advertising also declined in 2009, compared with 2008, and this was probably due in part to the recession. However, a growing population — in particular, the number of adults aged 60 and over — meant that the number of NHS sight tests taken in the year to March 2009 increased over the corresponding period of 2007/2008 and helped to sustain income from this source of revenue. Continue reading ‘Opticians & Optical Goods – Market Assessment’ »

Pipeline Insight: Leukemias Underserved patient populations offer potential for market growth

Despite major advances in treatment in the last decade, a considerable percentage of the leukemia population still has high unmet needs. Some key oncology companies have entered the leukemias market fairly recently while others are pursuing late-phase development in this indication, hoping to exploit the commercial potential of patient subgroups underserved by existing treatment options. ( http://www.bharatbook.com/detail.asp?id=134190&rt=Pipeline-Insight-Leukemias-Underserved-patient-populations-offer-potential-for-market-growth.html ) Continue reading ‘Pipeline Insight Leukemias Underserved Patient Populations Offer Potential For Market Growth’ »

Liver Cancer – Drug Pipeline Analysis and Market Forecasts to 2016

This is an essential source of information and analysis on the global liver cancer market. The report identifies the key trends shaping and driving the global liver cancer market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global liver cancer sector. ( http://www.bharatbook.com/detail.asp?id=134332&rt=Liver-Cancer-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016.html ) Continue reading ‘Liver Cancer Market Is Very Strong With Clinical Development’ »